Identification of igf1, slc4a4, wwox, and sfmbt1 as hypertension susceptibility genes in han chinese with a genome-wide gene-based association study

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yang, Hsin Chou ^a   Liang, Yu Jen ^a,c   Chen, Jaw Wen ^d   Chiang, Kuang Mao ^b,e   Chung, Chia Min ^b   Ho, Hung Yun ^f   Ting, Chih Tai ^f   Lin, Tsung Hsien ^g   Sheu, Sheng Hsiung ^g   Tsai, Wei Chuan ^h   Chen, Jyh Hong ^h   Leu, Hsin Bang ^d   Yin, Wei Hsian ⁱ   Chiu, Ting Yu ^j   Chern, Ching Iuan ^j   Lin, Shing Jong ^d   Tomlinson, Brian ^k   Guo, Youling ^l   Sham, Pak C ^l,m   Cherny, Stacey S ^l,m   Lam, Tai Hing ^l   Thomas, G Neil ⁿ   Pan, Wen Harn ^b,o   more..

^a INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

ⁱ CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^j MIN SHENG GENERAL HOSPITAL   (Taiwan)

^k CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^l UNIVERSITY OF HONG KONG   (Hong Kong)

^m UNIVERSITY OF HONG KONG   (Hong Kong)

ⁿ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^o NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE SODIUM COTRANSPORTER; INSULIN; SODIUM BICARBONATE COTRANPORTER 1; SOMATOMEDIN C; UNCLASSIFIED DRUG; OXIDOREDUCTASE; REPRESSOR PROTEIN; SFMBT1 PROTEIN, HUMAN; SLC4A4 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN;

ALLELE; AP3S1 GENE; ARTICLE; CARDIOVASCULAR DISEASE; CHINESE; COMMD7 GENE; CONTROLLED STUDY; CSF1 GENE; CSNK1G3 GENE; FURIN GENE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRB14 GENE; HLCS GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOGLYCEMIA; IGF1 GENE; INSULIN BLOOD LEVEL; KIAA1797 GENE; LACE1 GENE; LARS GENE; LC4A4 GENE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PROTEIN HOMEOSTASIS; SFMBT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC4A4 GENE; SYNE2 GENE; TMEM56 GENE; TTC12 GENE; WEIGHT REDUCTION; WWOX GENE; ASIAN; CASE CONTROL STUDY; CHINA; DNA MICROARRAY; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; STATISTICAL MODEL;

MUS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; SODIUM-BICARBONATE SYMPORTERS; TUMOR SUPPRESSOR PROTEINS;

EID: 84859043741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032907     Document Type: Article

References (97)

1. Pickering G, (1978) Normotension and hypertension: the mysterious viability of the false. The American Journal of Medicine 65: 561-563.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365: 217-223.
3. Pan WH, Chang HY, Yeh WT, Hsiao SY, Hung YT, (2001) Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996. Journal of Human Hypertension 15: 793-798.
4. Funke-Kaiser H, Reichenberger F, Kopke K, Herrmann SM, Pfeifer J, et al. (2003) Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation. Human Molecular Genetics 12: 423-433.
5. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, et al. (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180.
6. Lifton RP, (1996) Molecular genetics of human blood pressure variation. Science 272: 676-680.
7. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, et al. (1994) Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24: 63-69.
8. Julier C, Delepine M, Keavney B, Terwilliger J, Davis S, et al. (1997) Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Human Molecular Genetics 6: 2077-2085.
9. Xu X, Rogus JJ, Terwedow HA, Yang J, Wang Z, et al. (1999) An extreme-sib-pair genome scan for genes regulating blood pressure. American Journal of Human Genetics 64: 1694-1701.
10. Angius A, Petretto E, Maestrale GB, Forabosco P, Casu G, et al. (2002) A new essential hypertension susceptibility locus on chromosome 2p24-p25, detected by genomewide search. American Journal of Human Genetics 71: 893-905.
11. Gong M, Zhang H, Schulz H, Lee YA, Sun K, et al. (2003) Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Human Molecular Genetics 12: 1273-1277.
12. Wallace C, Xue MZ, Newhouse SJ, Marcano AC, Onipinla AK, et al. (2006) Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension. American Journal of Human Genetics 79: 323-331.
13. Koivukoski L, Fisher SA, Kanninen T, Lewis CM, von Wowern F, et al. (2004) Meta-analysis of genome-wide scans for hypertension and blood pressure in Caucasians shows evidence of susceptibility regions on chromosomes 2 and 3. Human Molecular Genetics 13: 2325-2332.
14. Guzman B, Cormand B, Ribases M, Gonzalez-Nunez D, Botey A, et al. (2006) Implication of chromosome 18 in hypertension by sibling pair and association analyses: putative involvement of the RKHD2 gene. Hypertension 48: 883-891.
15. Cowley AW, (2006) The genetic dissection of essential hypertension. Nature Reviews Genetics 7: 829-840.
16. Sabatti C, Service SK, Hartikainen AL, Pouta A, Ripatti S, et al. (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nature Genetics 41: 35-46.
17. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
18. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PIW, et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
19. Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, et al. (2007) Framingham Heart Study 100 K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Medical Genetics 8 (Suppl 1): S3.
20. Kato N, Miyata T, Tabara Y, Katsuya T, Yanai K, et al. (2008) High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Human Molecular Genetics 17: 617-627.
21. Psaty BM, O'Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, et al. (2009) Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circulation: Cardiovascular Genetics 2: 73-80.
22. Wang Y, O'Connell JR, McArdle PF, Wade JB, Dorff SE, et al. (2009) Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proceedings of the National Academy of Sciences of the United States of America 106: 226-231.
23. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nature Genetics 41: 666-676.
24. Org E, Eyheramendy S, Juhanson P, Gieger C, Lichtner P, et al. (2009) Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Human Molecular Genetics 18: 2288-2296.
25. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, et al. (2009) A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nature Genetics 41: 527-534.
26. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, et al. (2009) A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genetics 5: e1000564.
27. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al. (2009) Genome-wide association study of blood pressure and hypertension. Nature Genetics 41: 677-687.
28. Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, et al. (2011) Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nature Genetics 43: 531-538.
29. Yang H-C, Liang Y-J, Wu Y-L, Chung C-M, Chiang K-M, et al. (2009) Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. PLoS One 4: e5459.
30. Fox ER, Young JH, Li Y, Dreisbach AW, Keating BJ, et al. (2011) Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Human Molecular Genetics 20: 2273-2284.
31. Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, et al. (2010) Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genetics 6: e1001177.
32. Slavin TP, Feng T, Schnell A, Zhu X, Elston RC, (2011) Two-marker association tests yield new disease associations for coronary artery disease and hypertension. Human Genetics.
33. Hong K-W, Lim J-E, Oh B, (2011) A regulatory SNP in AKAP13 is associated with blood pressure in Koreans. Journal of Human Genetics 56: 205-210.
34. Hiura Y, Tabara Y, Kokubo Y, Okamura T, Miki T, et al. (2010) A genome-wide association study of hypertension-related phenotypes in a Japanese population. Circulation Journal 74: 2353-2359.
35. Yang H-C, Liang Y-J, Chung C-M, Chen J-W, Pan W-H, (2009) Genome-wide gene-based association study. BMC Proceedings 3: S135.
36. Fang Y-J, Deng H-B, Thomas GN, Tzang CH, Li C-X, et al. (2010) Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. Journal of Hypertension 28: 1203-1209.
37. Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M, et al. (2010) Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 26: 2474-2476.
38. Schut AF, Janssen JA, Deinum J, Vergeer JM, Hofman A, et al. (2003) Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 34: 1623-1627.
39. Yazdanpanah M, Rietveld I, Janssen JA, Njajou OT, Hofman A, et al. (2006) An insulin-like growth factor-I promoter polymorphism is associated with increased mortality in subjects with myocardial infarction in an elderly Caucasian population. The American Journal of Cardiology 97: 1274-1276.
40. Ruigrok YM, Slooter AJ, Bardoel A, Frijns CJ, Rinkel GJ, et al. (2005) Genes and outcome after aneurysmal subarachnoid haemorrhage. Journal of Neurology 252: 417-422.
41. Telgmann R, Dordelmann C, Brand E, Nicaud V, Hagedorn C, et al. (2009) Molecular genetic analysis of a human insulin-like growth factor 1 promoter P1 variation. FASEB Journal 23: 1303-1313.
42. Horio T, Kamide K, Takiuchi S, Yoshii M, Miwa Y, et al. (2010) Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension. Journal of Human Hypertension 24: 320-326.
43. te Velde SJ, van Rossum EF, Voorhoeve PG, Twisk JW, Delemarre van de Waal HA, et al. (2005) An IGF-I promoter polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36. BMC Endocrine Disorders 5: 5.
44. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, et al. (2004) Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. Journal of Clinical Endocrinology & Metabolism 89: 2640-2646.
45. 't Hart LM, Fritsche A, Rietveld I, Dekker JM, Nijpels G, et al. (2004) Genetic factors and insulin secretion: gene variants in the IGF genes. Diabetes 53 (Suppl 1): S26-30.
46. Voorhoeve PG, van Rossum EF, Te Velde SJ, Koper JW, Kemper HC, et al. (2006) Association between an IGF-I gene polymorphism and body fatness: differences between generations. European Journal of Endocrinology 154: 379-388.
47. Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, et al. (2005) Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiology, Biomarkers & Prevention 14: 1802-1809.
48. Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, et al. (2004) A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clinical Endocrinology 61: 195-203.
49. Rietveld I, Hofman A, Pols HA, van Duijn CM, Lamberts SW, et al. (2006) An insulin-like growth factor-I gene polymorphism modifies the risk of microalbuminuria in subjects with an abnormal glucose tolerance. European Journal of Endocrinology 154: 715-721.
50. Landmann E, Geller F, Schilling J, Rudloff S, Foeller-Gaudier E, et al. (2006) Absence of the wild-type allele (192 base pairs) of a polymorphism in the promoter region of the IGF-I gene but not a polymorphism in the insulin gene variable number of tandem repeat locus is associated with accelerated weight gain in infancy. Pediatrics 118: 2374-2379.
51. Knight J, Sham P, (2006) Design and analysis of association studies using pooled DNA from large twin samples. Behavior Genetics 36: 665-677.
52. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature Genetics 42: 105-116.
53. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A, (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72.
54. Ueki I, Ooi GT, Tremblay ML, Hurst KR, Bach LA, et al. (2000) Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proceedings of the National Academy of Sciences of the United States of America 97: 6868-6873.
55. Stratikopoulos E, Szabolcs M, Dragatsis I, Klinakis A, Efstratiadis A, (2008) The hormonal action of IGF1 in postnatal mouse growth. Proceedings of the National Academy of Sciences of the United States of America 105: 19378-19383.
56. Gawenis LR, Bradford EM, Prasad V, Lorenz JN, Simpson JE, et al. (2007) Colonic anion secretory defects and metabolic acidosis in mice lacking the NBC1 Na+/HCO3- cotransporter. Journal of Biological Chemistry 282: 9042-9052.
57. Hunt SC, Xin Y, Wu LL, Cawthon RM, Coon H, et al. (2006) Sodium bicarbonate cotransporter polymorphisms are associated with baseline and 10-year follow-up blood pressures. Hypertension 47: 532-536.
58. Taylor JY, Maddox R, Wu CY, (2009) Genetic and environmental risks for high blood pressure among African American mothers and daughters. Biological Research For Nursing 11: 53-65.
59. Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, et al. (2008) The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. Journal of Biological Chemistry 283: 21629-21639.
60. Peterson AJ, Mallin DR, Francis NJ, Ketel CS, Stamm J, et al. (2004) Requirement for sex comb on midleg protein interactions in Drosophila polycomb group repression. Genetics 167: 1225-1239.
61. Burstein E, Hoberg JE, Wilkinson AS, Rumble JM, Csomos RA, et al. (2005) COMMD proteins, a novel family of structural and functional homologs of MURR1. Journal of Biological Chemistry 280: 22222-22232.
62. Wiemuth D, Lott JS, Ly K, Ke Y, Teesdale-Spittle P, et al. (2010) Interaction of serum- and glucocorticoid regulated kinase 1 (SGK1) with the WW-domains of Nedd4-2 is required for epithelial sodium channel regulation. PLoS One 5: e12163.
63. Bansal V, Libiger O, Torkamani A, Schork NJ, (2010) Statistical analysis strategies for association studies involving rare variants. Nature Reviews Genetics 11: 773-785.
64. Kos CH, Le TC, Sinha S, Henderson JM, Kim SH, et al. (2003) Mice deficient in alpha-actinin-4 have severe glomerular disease. The Journal of Clinical Investigation 111: 1683-1690.
65. Jakobsson J, Karypidis H, Johansson JE, Roh HK, Rane A, et al. (2004) A functional C-G polymorphism in the CYP7B1 promoter region and its different distribution in Orientals and Caucasians. The Pharmacogenomics Journal 4: 245-250.
66. Li-Hawkins J, Lund EG, Turley SD, Russell DW, (2000) Disruption of the oxysterol 7alpha-hydroxylase gene in mice. Journal of Biological Chemistry 275: 16536-16542.
67. Hanasaki H, Takemura Y, Fukuo K, Ohishi M, Onishi M, et al. (2009) Fas promoter region gene polymorphism is associated with an increased risk for myocardial infarction. Hypertension Research 32: 261-264.
68. Zhang MC, Furukawa H, Tokunaka K, Saiga K, Date F, et al. (2008) Mast cell hyperplasia in the skin of Dsg4-deficient hypotrichosis mice, which are long-living mutants of lupus-prone mice. Immunogenetics 60: 599-607.
69. Pineda LL, Nakano A, Iijima M, Wada M, Yamasaki Y, et al. (2003) A new mutation, ataxia and male sterility (ams), of autoimmune-prone MRL/lpr mouse is not linked to lpr gene but associated with reduction of spleen size and alteration of lymphocyte subpopulations. Pathology International 53: 390-395.
70. Cooney GJ, Lyons RJ, Crew AJ, Jensen TE, Molero JC, et al. (2004) Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. EMBO Journal 23: 582-593.
71. Goenaga D, Hampe C, Carre N, Cailliau K, Browaeys-Poly E, et al. (2009) Molecular determinants of Grb14-mediated inhibition of insulin signaling. Molecular Endocrinology 23: 1043-1051.
72. Wang K, Li WD, Zhang CK, Wang ZH, Glessner JT, et al. (2011) A Genome-Wide Association Study on Obesity and Obesity-Related Traits. PLoS ONE 6.
73. Roy D, Sin SH, Damania B, Dittmer DP, (2011) Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood 118: E32-E39.
74. Howie BN, Donnelly P, Marchini J, (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genetics 5: e1000529.
75. Buil A, Martinez-Perez A, Perera-Lluna A, Rib L, Caminal P, et al. (2009) A new gene-based association test for genome-wide association studies. BMC Proceedings 3: S130.
76. Neale BM, Sham PC, (2004) The future of association studies: Gene-based analysis and replication. American Journal of Human Genetics 75: 353-362.
77. Pan WH, Fann CSJ, Wu JY, Hung YT, Ho MS, et al. (2006) Han Chinese cell and genome bank in Taiwan: Purpose, design and ethical considerations. Human Heredity 61: 27-30.
78. The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789-796.
79. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437: 1299-1320.
80. The International HapMap Consortium (2004) Integrating ethics and science in the international HapMap project. Nature Reviews Genetics 5: 467-475.
81. The International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
82. Puig O, Wang IM, Cheng P, Zhou P, Roy S, et al. (2010) Transcriptome profiling and network analysis of genetically hypertensive mice identifies potential pharmacological targets of hypertension. Physiological Genomics 42: 24-32.
83. Guo SW, Thompson EA, (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48: 361-372.
84. Devlin B, Roeder K, (1999) Genomic control for association studies. Biometrics 55: 997-1004.
85. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 38: 904-909.
86. Wilcoxon F, (1945) Individual comparisons by ranking methods. Biometrics Bulletin 1: 80-83.
87. Riva A, Kohane IS, (2004) A SNP-centric database for the investigation of the human genome. BMC Bioinformatics 5: 33.
88. Zaykin DV, Zhivotovsky LA, Westfall PH, Weir BS, (2002) Truncated product method for combining P-values. Genetic Epidemiology 22: 170-185.
89. Yang HC, Hsieh HY, Fann CSJ, (2008) Kernel-based association test. Genetics 179: 1057-1068.
90. Yang HC, Lin CY, Fann CSJ, (2006) A sliding-window weighted linkage disequilibrium test. Genetic Epidemiology 30: 531-545.
91. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
92. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
93. Kendall MG, (1938) A new measure of rank correlation. Biometrika 30: 81-93.
94. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, et al. (2009) Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325: 1246-1250.
95. Nica AC, Parts L, Glass D, Nisbet J, Barrett A, et al. (2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genetics 7: e1002003.
96. Horvath S, Laird NM, (1998) A discordant-sibship test for disequilibrium and linkage: No need for parental data. American Journal of Human Genetics 63: 1886-1897.
97. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 81: 559-575.